Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.

ABSTRACT:

Background

We isolated tumour endothelial cells (TECs), demonstrated their abnormalities, compared gene expression profiles of TECs and normal endothelial cells (NECs) by microarray analysis and identified several genes upregulated in TECs. We focused on the gene encoding biglycan, a small leucine-rich repeat proteoglycan. No report is available on biglycan expression or function in TECs.

Methods

The NEC and TEC were isolated. We investigated the biglycan expression and function in TECs. Western blotting analysis of biglycan was performed on sera from cancer patients.

Results

Biglycan expression levels were higher in TECs than in NECs. Biglycan knockdown inhibited cell migration and caused morphological changes in TECs. Furthermore, immunostaining revealed strong bigl

SUBMITTER: Yamamoto K 

PROVIDER: S-EPMC3304426 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature